Ketoprofen in horses: Metabolism, pharmacokinetics, and effects on inflammatory biomarkers
Drug Testing and Analysis · 2024
DOI: 10.1002/dta.3543 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Testing and Analysis, 2024. Verfasst von Heather K Knych und 4 weiteren Autor:innen. Beteiligte Einrichtung: K.L. Maddy Equine Analytical Pharmacology Laboratory, School of Veterinary Medicine, University of California, Davis, California, USA. Hauptthemen laut MEDLINE: Ketoprofen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Racing Medication and Testing Consortium, California Horse Racing Board.
Abstract (Originalsprache)
Ketoprofen is an anti‐inflammatory drug that is commonly administered to racehorses for the alleviation of musculoskeletal pain and inflammation. This study represents a comprehensive examination of the metabolism (in vivo and in vitro), pharmacokinetics and ex vivo pharmacodynamics, of ketoprofen in horses. The in vitro metabolism as well as specific enzymes responsible for metabolism was determined by incubating liver microsomes and recombinant CYP450 and UGT enzymes with ketoprofen. For the in vivo portion, 15 horses were administered a single intravenous dose of 2.2‐mg/kg ketoprofen. Blood and urine samples were collected prior to and up to 120 h post‐drug administration. Additional blood samples were collected at select time points and were stimulated with calcium ionophore or lipopolysaccharide, ex vivo, to induce eicosanoid production. Drug, metabolite, and eicosanoid concentrations were determined using LC–MS/MS. Incubation of ketoprofen with equine liver microsomes generated 3‐hydroxy ketoprofen, an unidentified hydroxylated metabolite, and ketoprofen glucuronide. Recombinant equine CYP2C23 produced the greatest amount of hydroxylated ketoprofen and recombinant equine UGT1A2 generated ketoprofen glucuronide. Dihydro, 3‐hydroxy, and glucuronide metabolites were identified in blood and urine samples. The Vd ss was 0.280, 0.385, and 0.319 L/kg for total ketoprofen, S (+) ketoprofen, and R (−) ketoprofen, respectively. The mean half‐life was 6.01 h for total ketoprofen, 2.22 h for S (+) ketoprofen, and 1.72 h for R (−) ketoprofen. Stimulation of ketoprofen‐treated blood with lipopolysaccharide and calcium ionophore resulted in an inhibition of TXB 2 , PGE 2 , PGF 2alpha , LTB 4 , and 15(s)‐HETE production for up to 120 h post‐drug administration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- K.L. Maddy Equine Analytical Pharmacology Laboratory, School of Veterinary Medicine, University of California, Davis, California, USA.
- Department of Veterinary Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, California, USA.
- Department of Population Health and Reproduction, School of Veterinary Medicine, University of California, Davis, California, USA.
- MH Gluck Equine Research Center, University of Kentucky College of Agriculture, Lexington, Kentucky, USA.
- School of Veterinary Medicine, University of California, Davis, California, USA.
ORCID-Profile: Heather K Knych
Förderung
- Racing Medication and Testing Consortium
- California Horse Racing Board
Zitieren
APA
Knych, H. K., McKemie, D. S., Kass, P. H., Stanley, S. D., & Blea, J. (2024). Ketoprofen in horses: Metabolism, pharmacokinetics, and effects on inflammatory biomarkers. Drug Testing and Analysis. https://doi.org/10.1002/dta.3543
Vancouver
Knych HK, McKemie DS, Kass PH, Stanley SD, Blea J. Ketoprofen in horses: Metabolism, pharmacokinetics, and effects on inflammatory biomarkers. Drug Testing and Analysis. 2024. doi:10.1002/dta.3543
BibTeX
@article{Knych2024,
author = {Knych, Heather K and McKemie, Daniel S and Kass, Philip H and Stanley, Scott D and Blea, Jeff},
title = {Ketoprofen in horses: Metabolism, pharmacokinetics, and effects on inflammatory biomarkers},
journal = {Drug Testing and Analysis},
year = {2024},
doi = {10.1002/dta.3543}
}
EUVIMED